Proshares Trust ZBIO
ZBIO
$27.94 +0.97 (+3.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Interest Expenses (2026)

Updated

Zenas BioPharma's Interest Expenses was $1.72 million in Q2 2026, up 367.4% from the prior quarter.

Analysis

Zenas BioPharma (ZBIO) Interest Expenses (2026) Analysis & Trends

For FY2025, Interest Expenses at Zenas BioPharma came in at $7.33 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zenas BioPharma 1.71 Bn 1.71 Bn - 1.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.72 Mn
Mar 31, 2026 368,000.00
API Access

Zenas BioPharma Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ZBIO&period=max&api_key=YOUR_API_KEY